| #261 |
Emile Marcus Kenning |
Sophos Limited |
2 |
| #261 |
Kostas Papadopoulos |
Padlock Therapeutics |
2 |
| #261 |
Ana PEREIRA RIBEIRO |
Immunocore Limited |
2 |
| #261 |
Saad Jbabdi |
Oxford University |
2 |
| #261 |
Andrea Guerrero Corella |
— |
2 |
| #261 |
Karen PARRISH |
BOE |
2 |
| #261 |
Nichola Kyle |
Infineum International Limited |
2 |
| #261 |
Aksana Rimu Khan |
— |
2 |
| #261 |
Terence M. O'Brien |
ExxonMobil |
2 |
| #261 |
Katie Warnaby |
Oxford University |
2 |
| #261 |
Christopher Toumazou |
Imperial College Innovations |
2 |
| #261 |
Kathrin Skibbe |
Adaptimmune Limited |
2 |
| #261 |
Bruno Laugel |
Adaptimmune Limited |
2 |
| #261 |
Lindsay Jane Bawden |
Singapore Volition Pte. Limited |
2 |
| #261 |
Hervé Jean Claude Deboves |
Ucb Biopharma Srl |
2 |
| #261 |
Garth Hamilton |
Adaptimmune Limited |
2 |
| #261 |
Angeliki SIOKOU |
P2I |
2 |
| #261 |
Ian Francis |
Lightship Medical Limited |
2 |
| #261 |
Delwyn EVANS |
P2I |
2 |
| #261 |
Michael Robert Osborne |
United Kingdom Atomic Energy Authority |
2 |
| #261 |
Guy Alexander Davies |
Sophos Limited |
2 |
| #261 |
John David Sutherland |
Isis Innovation Limited |
2 |
| #261 |
Sarah Scaife |
Oxitec |
2 |
| #261 |
Maurits KLEIJNEN |
Immunocore Limited |
2 |
| #261 |
Sebastian Troy |
Kioxia |
2 |
| #261 |
Lindsey Ann Needham |
Singapore Volition Pte. Limited |
2 |
| #261 |
Roger Clive Saunders |
Ca |
2 |
| #261 |
Christine Wilkinson Blanc |
Akamis Bio Limited |
2 |
| #261 |
Rebecca McKavanagh |
Oxford University |
2 |
| #261 |
Vijaykumar KARUPPIAH |
Immunocore Limited |
2 |
| #261 |
Adele FAULKNER |
Forge Therapeutics |
2 |
| #261 |
Aimee Cossins |
Ipsen Bioinnovation Limited |
2 |
| #261 |
Jonathan Leslie Allis |
Oxford Magnet Technology Limited |
2 |
| #261 |
Benjamin Peter Delo |
IBM |
2 |
| #261 |
Paul Naccache |
Schlumberger Technology |
2 |
| #261 |
Irene Tracey |
Oxford University |
2 |
| #261 |
Robert M Adlington |
Isis Innovation Limited |
2 |
| #261 |
Ian Alexander Weston Bell |
ExxonMobil |
2 |
| #261 |
Jack Astbury |
Tokamak Energy |
2 |
| #261 |
Athithan Dharmaratnam |
Schlumberger Technology |
2 |
| #261 |
Steven Chance |
Oxford University |
2 |
| #261 |
Matthew Habgood |
— |
2 |
| #261 |
Robert Muir-Wood |
Risk Management Solutions |
2 |
| #261 |
Rachel Alison Fallon |
Amersham International Plc |
2 |
| #261 |
Thomas Paul Cain |
Ucb Biopharma Srl |
2 |
| #261 |
Jane Galsworthy |
Infineum International Limited |
2 |
| #261 |
Rajlakshmi Purkayastha |
Johnson Matthey Plc |
2 |
| #261 |
Robert James Townsend |
Bayer Healthcare |
2 |
| #261 |
Sanjoy Kumar Khataniar |
Schlumberger Technology |
2 |
| #261 |
Andrew Michael Shand |
Schlumberger Technology |
2 |